Lexicon Pharmaceuticals | LXRX - Market Capitalization

Stock Price
1.84
Daily Change
-0.03 -1.60%
Monthly
12.20%
Yearly
220.00%
Q2 Forecast
1.83

Lexicon Pharmaceuticals reported $460.5M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 168.02B 10.39B Apr/2026
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 102M 4M Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024